+467.0%
MRNA vs FSLY
+210.9%
+256.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FSLY | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +2.0% | +3.4% | +5.6% |
| 7D | -1.1% | +12.5% | -13.6% | 0.0% |
| 30D | +126.1% | -18.8% | +144.9% | +125.7% |
| 3M | +190.0% | +22.7% | +167.4% | +183.8% |
| 6M | +157.2% | -3.7% | +160.9% | +151.7% |
| YTD | +388.2% | +127.5% | +260.7% | +363.6% |
| 1Y | +467.0% | +193.5% | +273.5% | +405.1% |
| All | +467.0% | +210.9% | +256.2% | +405.1% |
Cumulative growth
Daily Returns
Daily percentage return beside FSLY.
Daily Out/Under-Performance
Portfolio return minus FSLY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FSLY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FSLY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling